Tolerability and efficacy of high-dose moclobemide alone and in combination with lithium and trazodone.
Magder
D M
DM
Aleksic
I
I
Kennedy
S H
SH
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D006801:Humans; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use*; D008297:Male; D020912:Moclobemide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D014196:Trazodone / Q000009:adverse effects* / Q000627:therapeutic use*
D018687:Antidepressive Agents, Second-Generation; D008996:Monoamine Oxidase Inhibitors; D008094:Lithium; D020912:Moclobemide; D014196:Trazodone